MRD’s Potential Role in Treating Acute Myeloid Leukemia
0 Views
administrator
07/04/23
Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.
-
Category
Show more
Facebook Comments
No comments found